Dr. Reddy's Laboratories Limited (FRA:RDDA)
Germany flag Germany · Delayed Price · Currency is EUR
12.00
-0.40 (-3.23%)
Last updated: Feb 20, 2026, 8:25 AM CET

Dr. Reddy's Laboratories Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
9,96110,32111,4038,6048,4758,726
Market Cap Growth
-10.75%-9.49%32.53%1.52%-2.88%39.74%
Enterprise Value
9,85410,26710,8168,2588,3928,780
Last Close Price
12.0012.2413.6610.339.8810.22
PE Ratio
18.5716.8618.4117.0330.3243.47
PS Ratio
3.042.933.673.123.333.95
PB Ratio
2.802.833.653.323.754.33
P/TBV Ratio
4.084.244.283.924.505.64
P/FCF Ratio
28.6750.3735.3116.1453.1328.86
P/OCF Ratio
16.6520.5322.5613.0425.4220.99
EV/Sales Ratio
3.052.913.483.003.303.97
EV/EBITDA Ratio
12.2410.6712.2611.1614.8216.50
EV/EBIT Ratio
15.8312.9814.8213.7919.7022.91
EV/FCF Ratio
28.3650.1033.4915.5052.6129.04
Debt / Equity Ratio
0.180.140.070.060.180.18
Debt / EBITDA Ratio
0.790.520.250.200.710.66
Debt / FCF Ratio
1.852.470.690.282.521.17
Net Debt / Equity Ratio
-0.04-0.03-0.22-0.21-0.05-0.02
Net Debt / EBITDA Ratio
-0.17-0.12-0.77-0.73-0.22-0.09
Net Debt / FCF Ratio
-0.40-0.59-2.12-1.02-0.78-0.16
Asset Turnover
0.660.740.790.800.770.76
Inventory Turnover
2.062.012.062.142.092.15
Quick Ratio
1.181.161.721.581.241.07
Current Ratio
1.881.922.582.381.931.78
Return on Equity (ROE)
16.10%18.53%21.77%21.38%12.96%10.51%
Return on Assets (ROA)
7.96%10.37%11.56%10.86%8.04%8.27%
Return on Invested Capital (ROIC)
14.38%19.98%25.30%21.99%15.03%13.42%
Return on Capital Employed (ROCE)
16.40%20.10%22.50%22.60%18.10%18.10%
Earnings Yield
5.38%5.93%5.43%5.87%3.30%2.30%
FCF Yield
3.49%1.98%2.83%6.19%1.88%3.46%
Dividend Yield
0.51%0.71%0.65%0.87%0.72%0.57%
Payout Ratio
11.77%11.78%11.94%11.05%17.59%24.06%
Buyback Yield / Dilution
0.15%-0.08%-0.19%-0.03%-0.01%-0.14%
Total Shareholder Return
0.67%0.63%0.46%0.84%0.71%0.43%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.